Haisco Pharmaceutical Group Co., Ltd.
Clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd., explained in plain language.
-
New psoriasis cream shows early promise in small trial
Disease control OngoingThis study tests a new cream called HSK44459 in healthy volunteers and people with plaque psoriasis. The first part checks safety and how the body processes the cream. The second part looks at whether different strengths of the cream can improve psoriasis symptoms over 8 weeks. A…
Phase: PHASE1, PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New inhaler aims to help COPD patients breathe easier
Disease control OngoingThis study tests an experimental inhaler called HSK39004 in 180 adults with COPD, a long-term lung disease that makes breathing hard. Participants will use the inhaler or a placebo for 4 weeks to see if it safely improves lung function. The goal is to control the disease and ease…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New inhaled drug HSK39004 shows promise for COPD in early trial
Disease control OngoingThis Phase 2 trial tests an inhaled drug called HSK39004 in 12 people with COPD. The study measures how much drug gets into the blood and how it affects lung function over 12 hours. It compares HSK39004 to an existing treatment to see if it works as well or better.
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Healthy volunteers needed to test drug interaction
Knowledge-focused OngoingThis study looks at how the drug rifampicin changes the way another drug, HSK31858, is processed in the body. It involves 24 healthy adults aged 18 to 45. The goal is to measure drug levels in the blood, not to treat any disease.
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Healthy volunteers needed to test drug interaction in new study
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how a common antifungal drug, itraconazole, changes the way the body handles an experimental drug called HSK31858. It involves 24 healthy adults aged 18 to 45. Participants will take both drugs in a fixed order, and researchers will measure drug levels in the …
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC